Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865199 · ClinicalTrials.gov registry record · NA

A Narrative Intervention to Decrease Abortion Stigma

A NA study of Stigma, Social, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
215
Enrollment target
1
Study location

NCT03865199: Completed NA study of Stigma, Social, sponsored by University of Chicago.

NCT03865199 is a NA study of Stigma, Social that has completed, run by University of Chicago. The registered enrollment target is 215 participants, below the 617-participant average among 10 other Stigma, Social trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865199, a NA study of Stigma, Social, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
215 participants
Enrollment target
1
Study location

Study Summary

Abortion stigma is pervasive in the United States. It operates across multiple levels, including the individual, community, and structural. While abortion itself does not cause mental health problems, due to stigma, women who undergo abortion are at risk of suffering negative psychological responses including thought suppression and isolation, which can result in psychological distress. Few intervention studies have addressed abortion stigma. Research in other disciplines, in particular mental health, has demonstrated the importance of self-validation in improved coping. Drawing from psychologists' use of writing in cognitive therapy and the discipline of Narrative Medicine's emphasis on narrative as a mechanism of healing, the proposed study attempts to test a novel intervention to reduce individual level abortion stigma. The study will be a randomized controlled trial evaluating a narrative intervention to reduce individual level abortion stigma. The principal research question is: can a narrative intervention that aims to positively frame the abortion experience decrease individual level abortion stigma? An additional research question is: will women who take part in a narrative intervention to reduce abortion stigma have improved psychological responses to the abortion? Women in the intervention group will view a digital story on a tablet intending to provide education and normalization and then respond to a writing prompt aimed at cognitive restructuring. The control group will receive care as usual.

Primary Outcome

Difference in score on the Individual Level Abortion Stigma Scale (ILAS) between baseline and follow-up: The ILAS is a validated 20-item scale that measures individual level stigma with four subscales including: worries about judgment, isolation, self-judgment, and community condemnation. The ILAS has a maximum score of five; in the study that established validity of this scale, the mean score was 1.35 with a standard deviation of 0.63. A higher score indicates greater stigma and a lower score i

Conditions Studied

Interventions

  • BEHAVIORAL Narrative Intervention

Study Locations (1)

Illinois

  • Planned Parenthood - Chicago

Trial Details

FieldValue
Enrollment Target 215 participants
Start Date 2019-06-16
Est. Completion 2020-02-05
Phase NA
University of Chicago

796 total trials

What the finished NCT03865199 record still lists

NCT03865199 is an interventional study that assigns participants to a tested intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap, below the 617-participant average among 10 other Stigma, Social trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Stigma, Social appearing as the primary indexed condition, and to 1 intervention - of which Narrative Intervention is the first listed.

NCT03865199 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03865199 about?

NCT03865199 is a clinical study titled "A Narrative Intervention to Decrease Abortion Stigma". Abortion stigma is pervasive in the United States. It operates across multiple levels, including the individual, community, and structural. While abortion itself does not cause mental health problems, due to stigma, women who undergo abortion are at risk of suffering negative psychological responses...

What is the current status of trial NCT03865199?

This trial is currently completed. It is a NA study. The enrollment target is 215 participants. The study started on 2019-06-16. Estimated completion is 2020-02-05.

What conditions does trial NCT03865199 study?

This clinical trial studies the following conditions: Stigma, Social.

What interventions are being tested in trial NCT03865199?

The interventions under investigation include: Narrative Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03865199?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865199 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stigma, Social

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03865199's enrollment target sits among peer trials

215 7th of 10 higher than 4 of 10 other Stigma, Social trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stigma, Social trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05134012 · 215 participants · Phase 3

    RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

  • NCT05169970 · 215 participants · Phase 2

    A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

  • NCT05197270 · 215 participants · Phase 1

    4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • NCT05230199 · 215 participants · NA

    Sensory Optimization of the Hospital Environment

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03865199, the US trial registry maintained by the National Library of Medicine. NCT03865199 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.